BioNTech Pfizer Accelerates Vaccine Delivery

BioNTech Pfizer

The Commission has today agreed with BioNtech-Pfizer to accelerate the delivery of its mRNA vaccine to Member States, starting in a few weeks. In Q1 of 2022, BioNtech-Pfizer will deliver an additional 20 million vaccine doses (5 million in January, 5 million in February and 10 million in March). These doses come on top of…